low

ART should be started in all TB patients living with HIV irrespective of their CD4 counts.

All children living with HIV after successful completion of treatment for TB disease should receive
isoniazid for an additional 6 months.

In children living with HIV who are less than 12 months of age, only those who have contact with a
TB case and who are evaluated for TB (using investigations) should receive six months IPT if the
evaluation shows no TB disease.

Routine HIV testing should be offered to all patients with presumptive and diagnosed TB.

TB patients should be screened for diabetes at the start of TB treatment,
where resources for diagnosis are available. Type of screening and
diagnostic tests should be adapted to the context of local health
systems and the availability of resources, while awaiting additional
evidence on the best screening and diagnostic approach.

Treatment and case management of TB in people with diabetes should
be provided in accordance with existing TB treatment guidelines and
international standards. The same TB treatment regimen should be
prescribed to people with diabetes as for people without diabetes.

Adapt and implement good practices in occupational health and the management of HIV and TB in
the workplace from all sectors.

Develop and implement training programmes for pre-service, in-service and continuing education
on TB and HIV prevention, treatment and care services, integrating with existing programmes and
including managers and worker representatives as well as health workers.

Establish schemes for reasonable accommodation and compensation, including, as appropriate,
paid leave, early retirement benefits and death benefits in the event of occupationally-acquired
disease.

Provide free HIV and TB treatment for health workers in need facilitating the delivery of these services in a non-stigmatizing, gender-sensitive, confidential, and convenient setting when there is no staff clinic and/or their own facility does not offer ART, or where health workers prefer services off-site.